EQUITY•SECTORAL / THEMATIC
Nippon India Pharma Fund Direct Plan IDCW Reinvestment
3 Year return
18.76%
NAV on August 10, 2026
175.6974
1D Returns
-0.03%
Launched on January 2013(13 years)
Investment Details
₹100
Minimum SIP Amount
₹5000
Minimum one time investment
Fund has no lock-in period
Calculate Returns
Based on past performance of this fund
₹
Your Investment₹3,600
Gain
34.97%₹1,259
Total Value ₹4,859
Risk Involved
Your principal will be at
Very High Risk
Scheme Information
Asset Under Management
₹9,044.23 Cr.
Expense Ratio
1% (inclusive of GST)
Exit Load
1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Ratings
0
Ratings by other agencies
Value Research
0
Crisil
0
Morning Star
0
Tax Implications
Withdrawal within 1 year:
20% tax on gains
Withdrawal after 1 year:
12.5% tax on gains above ₹1.25 lakh per financial year
Nippon India Mutual Fund Manager
AS
Akshay Sharma
Fund Manager since Dec 2022
AS
Amber Singhania
Fund Manager since Mar 2026
DD
Divya Dutt Sharma
Fund Manager since Sep 2025
KD
Kinjal Desai
Fund Manager since Mar 2026
LM
Lokesh Maru
Fund Manager since Sep 2025
SR
Sailesh Raj Bhan
Fund Manager since Mar 2005
Fund House Details
Nippon India Mutual Fund
Asset management company
AUM
₹7,67,506.42 Cr.
No. of Schemes
338
Setup Date
June 1995
Peer Comparison
Comparison with other similar funds
| Funds | 3 Y Returns | ARQ Rating |
|---|---|---|
| Aditya Birla Sun Life PSU Equity Fund | 24.7224% | 0 |
| SBI PSU Fund | 25.2643% | 0 |
| LIC MF Infrastructure Fund | 26.704% | 0 |
Schemes by Nippon India Mutual Fund
List of mutual fund schemes by AMC
Funds
3 Years Returns
The Nippon India Pharma Fund Direct Plan IDCW Reinvestment is offered by Nippon Life India Asset Management Limited. The fund falls under the category of Sectoral/Thematic Funds. As a sectoral fund, it focuses on investing primarily in companies within the pharmaceutical sector. The reinvestment option allows the fund to reinvest the dividends earned to enhance the overall performance of the fund in the long run. This is an open-ended fund that allows investors to buy and sell units on any business day. The fund’s expense ratio is slightly higher than the category average.
Investment Objective of the Scheme
The main investment objective of the Nippon India Pharma Fund Direct Plan IDCW Reinvestment is to generate capital appreciation over the long term by predominantly investing in companies operating in the pharmaceutical sector. The fund aims to capitalise on growth opportunities within this specific sector.
Key Features of The Fund
5-year return
13.7604%
Expense Ratio
1%
Fund Manager
Akshay Sharma
Fund Size
₹9044.23 Cr.
Risk Profile
Very High
Is This Scheme Right for Me?
This fund might be suitable for investors who are bullish on the pharmaceutical sector and are looking for long-term capital growth. Since the fund predominantly invests in the pharma sector, investors should be prepared to take on higher risks. Before making an investment decision, interested investors should assess their own risk tolerance and returns expectation. Having a clear understanding of the pharma sector's dynamics is also essential.
AMC Contact Details
| Name | Nippon India Mutual Fund |
| Launch Date | June 1995 |
| Address | Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013 |
| Contact | 1860 266 0111 |
| customercare@nipponindiaim.in | |
| Website | https://mf.nipponindiaim.com/ |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.
Combat Inflation with SIP Investments
Compound growth and steady contributions through SIPs balance the negative effects of inflation, guaranteeing that your money increases faster than inflation. Use Angel One's free SIP calculator online to estimate potential returns and plan your inflation-hedging investment strategy effectively.
FAQs
What is today's NAV of Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of Nippon India Pharma Fund Direct Plan IDCW Reinvestment on August 10, 2026, is ₹175.6974
What is the AUM of Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
Short for Asset Under Management, AUM means the total assets held by a mutual fund scheme. The AUM of the fund changes every day based on the fluctuation in the price of the underlying assets. Fund houses don't update AUM on a daily basis. They only update it at the end of the month and release it within a few days of the following month. The AUM of Nippon India Pharma Fund Direct Plan IDCW Reinvestment, is ₹9044.23 crore.
What is the expense ratio of Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
The expense ratio is the annual charges you pay to the mutual fund house for managing your investments. It is a percentage of Assets Under Management. It is deducted from the fund's returns. The expense ratio of Nippon India Pharma Fund Direct Plan IDCW Reinvestment is 1%
What are the returns of Nippon India Pharma Fund Direct Plan IDCW Reinvestment since inception?
The Nippon India Pharma Fund Direct Plan IDCW Reinvestment was launched on January 01, 2013. The fund has delivered a CAGR of undefined since inception.
What is the minimum SIP amount to invest in Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
A Systematic Investment Plan (SIP) in mutual funds allows you to invest small amounts periodically instead of a one-time investment. The frequency of investment can be monthly, quarterly, half-yearly or annually, as per your convenience. The minimum SIP for Nippon India Pharma Fund Direct Plan IDCW Reinvestment is ₹100.
How do I invest in Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
- Make sure you are logged in to Angel One.
- Select the type of investment: SIP or one-time.
- In case of an SIP, select the amount and date and click ‘Start SIP’. In case of a one-time investment, enter just the amount.
- Proceed by clicking the pay button and choosing your mode of payment.
- Your portfolio will be updated with this investment in 3-5 working days.
How to start an SIP in Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
- Click on the ‘Invest’ button.
- Enter your desired SIP amount and the SIP date.
- You can uncheck the ‘Make first payment now’ box if you don’t want to make the payment right away.
- Choose your payment method between UPI and Net Banking.
- Make your payment.
- Your SIP is created.
How do I automate an SIP in Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
- Once you create an SIP, click on ‘Set up autopay’
- Select your desired verification method - debit card, net banking or Aadhar method credentials - and click on submit.
- Once you verify the OTP, your mandate request will be created.
How can I withdraw/redeem my investment in Nippon India Pharma Fund Direct Plan IDCW Reinvestment?
- Go to the ‘Investments’ section and click on the mutual fund scheme you want to withdraw.
- Enter the amount you want to withdraw and tap the ‘Withdraw’ button.
- Verify the details on the ‘Confirm withdraw’ screen.
- Select the bank account in which you want to receive the funds.
- You will receive your funds within three working days of placing the order.
- You can track your order in the ‘Orders’ section.
ENTER AMOUNT
₹
₹4,859 in 3Y at 18.7577% returns
SIP Date1st of every month
Your next SIP Payment will be on 10 September 2026
By proceeding, you accept AngelOne's T&C
